Home
About
Overview
Sharing Data
ORCID
Help
History (61)
Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans.
Tepotinib Efficacy and Safety in Patients with MET Exon 14 Skipping NSCLC: Outcomes in Patient Subgroups from the VISION Study with Relevance for Clinical Practice.
Overcoming acquired resistance to cetuximab by dual targeting HER family receptors with antibody-based therapy.
FAK and paxillin, two potential targets in pancreatic cancer.
MET molecular mechanisms and therapies in lung cancer.
See All 61 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
MET molecular mechanisms and therapies in lung cancer.
MET molecular mechanisms and therapies in lung cancer. Cell Adh Migr. 2010 Jan-Mar; 4(1):146-52.
View in:
PubMed
subject areas
Animals
Humans
Lung Neoplasms
Proto-Oncogene Proteins c-met
authors with profiles
Ravi Salgia